GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES

Technology
E-053-2019
Patent ID
E-053-2019-0-US-12
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
 
Publication Number
 
Application Number
17/429,391
IC
NCI
Date Filed
Date Issued
 
Patent PDF
 
Related Technologies
TAB-4022     Genetically Modified Hematopoietic Stem And Progenitor Cells (HSPCs) And Mesenchymal Cells As A Platform To Reduce Or Prevent Metastasis, Treat Autoimmune And Inflammatory Disorders, And Rebalance The Immune Milieu And Dysregulated Niches